- Home
- KROS vs CODI Comparison
KROS vs CODI Comparison
Compare KROS & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- CODI
- Stock Information
- Founded
- KROS 2015
- CODI 2005
- Country
- KROS United States
- CODI United States
- Employees
- KROS N/A
- CODI N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- CODI Home Furnishings
- Sector
- KROS Health Care
- CODI Consumer Discretionary
- Exchange
- KROS Nasdaq
- CODI Nasdaq
- Market Cap
- KROS 565.0M
- CODI 480.0M
- IPO Year
- KROS 2020
- CODI 2006
- Fundamental
- Price
- KROS $15.91
- CODI $8.49
- Analyst Decision
- KROS Buy
- CODI Buy
- Analyst Count
- KROS 14
- CODI 2
- Target Price
- KROS $20.56
- CODI $26.00
- AVG Volume (30 Days)
- KROS 424.2K
- CODI 1.8M
- Earning Date
- KROS 11-05-2025
- CODI 10-29-2025
- Dividend Yield
- KROS N/A
- CODI 11.79%
- EPS Growth
- KROS N/A
- CODI N/A
- EPS
- KROS 0.47
- CODI N/A
- Revenue
- KROS $232,844,000.00
- CODI $2,198,233,000.00
- Revenue This Year
- KROS $6,657.47
- CODI $15.09
- Revenue Next Year
- KROS N/A
- CODI $8.26
- P/E Ratio
- KROS $34.14
- CODI N/A
- Revenue Growth
- KROS 85820.30
- CODI 11.87
- 52 Week Low
- KROS $9.12
- CODI $5.98
- 52 Week High
- KROS $72.37
- CODI $24.32
- Technical
- Relative Strength Index (RSI)
- KROS 54.08
- CODI 73.73
- Support Level
- KROS $15.50
- CODI $6.48
- Resistance Level
- KROS $16.44
- CODI $6.91
- Average True Range (ATR)
- KROS 0.57
- CODI 0.45
- MACD
- KROS -0.01
- CODI 0.19
- Stochastic Oscillator
- KROS 59.87
- CODI 75.13
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.